Content Type: Article

  • Family Office Symposium 2024 | Key Takeaways

    Family Office Symposium 2024 | Key Takeaways

    ARTICLE

    Family Office Symposium 2024 | Key Takeaways

    May 8 – 10, 2024

    Read time: 2 min

    Key takeaways
    Overview

    McDermott’s Family Office Symposium 2024 gathered more than 275 family office executives to explore creative solutions to navigate complexity and gain fresh perspectives on the challenges they face. Over two days, participants heard from family office leaders and McDermott partners on the latest developments impacting family offices and exchanged insights on strategies to manage wealth and legacy in a dynamic environment.

    This report provides key takeaways from each of the following sessions, including highlights from live polling conducted during the event to provide additional context and insights:

    • Here is What We Do Know: Potential Federal Tax Policy Developments
    • Politics, Privacy, Power & (Non)profits
    • Stress Testing Your FLP: The Anatomy of an FLP Challenge
    • This Ain’t Our First Rodeo: How to Successfully Navigate a Large Trust Administration
    • Bridging the Divide: Successful Generational Transitions
    • Navigating Tax Controversies with a Reinvigorated IRS
    • We Are Here … Now What? Beyond the Basics of the Corporate Transparency Act
    • Should I Stay or Should I Go? Residency and State Income Tax Planning
    • From 1.0 to 2.0: Life After the Sale of the Family Business and Other Major Events
    • Updating the Family Office Toolkit: Recent Developments
    • World on Fire: Managing Wealth Mobility in a Complex Global Environment
    • Cybersecurity, Employment Litigation and Other Threats: Reinforcing the Family Office
    • Strategies to Support Struggling Family Members
    • Unhappy Campers: Managing Family Member Exits
    In depth
    Authors
    More insights

  • Texas Court Issues Nationwide Injunction Striking Down the FTC Noncompete Ban

    Texas Court Issues Nationwide Injunction Striking Down the FTC Noncompete Ban

    ARTICLE / CLIENT ALERT

    Texas Court Issues Nationwide Injunction Striking Down the FTC Noncompete Ban

    August 21, 2024

    Read time: 2 min

    Key takeaways
    Overview

    On August 20, 2024, the US District Court for the Northern District of Texas issued a nationwide injunction barring the Federal Trade Commission’s (FTC) Final Rule that bans all noncompete agreements. The court’s findings focused on two key points:

    • The FTC exceeded its statutory authority: The court found that the FTC lacked the authority to impose the Final Rule under Section 6(g) of the Federal Trade Commission Act of 1914, a “housekeeping statute” that does not confer “substantive rulemaking power.”
    • The Final Rule is “arbitrary and capricious”: The court also found that the Final Rule is “arbitrary and capricious” under the Administrative Procedure Act, the federal law governing agency “rulemaking,” because it is “unreasonably overbroad without a reasonable explanation” and “imposes a one-size-fits-all approach with no end date.”

    What Does This Mean for Business Entities?

    Due to its nationwide scope, this injunction means the Final Rule will not take effect on September 4, 2024, as planned. For now, employers do not need to notify employees that their noncompete agreements are rescinded, nor will businesses be precluded from entering into noncompetition agreements with new employees.

    An FTC spokesperson said the agency was “disappointed” and is “seriously considering a potential appeal” to the US Court of Appeals for the Fifth Circuit. The spokesperson added that the “decision does not prevent the FTC from addressing noncompetes through case-by-case enforcement actions.”

    McDermott will provide updates on further developments as they arise.

    In depth
    Authors

    Brian Mead

    Partner

    Chicago

    More insights

  • The Vifor Case: Disparagement Reloaded?

    The Vifor Case: Disparagement Reloaded?

    ARTICLE / CLIENT ALERT

    The Vifor Case: Disparagement Reloaded?

    August 21, 2024

    Read time: 8 min

    Key takeaways
    Overview

    On July 22, 2024, the European Commission (EC) accepted commitments proposed by Vifor Pharmaceuticals to address disparagement concerns under Article 102 TFEU. This is the EC’s first pure disparagement case and its second investigation into disparagement practices in the pharmaceutical industry. The only other ongoing investigation into disparagement, concerning Teva Pharmaceuticals, is still underway, though its conclusion is much anticipated given that it will address the alleged misuse of divisional patents and disparagement of competitors in order to safeguard its multiple sclerosis treatment, Copaxone.*

    In depth

    Procedural Background

    Disparagement, or, disseminating negative and often misleading information about a competitor’s products to discourage its use, is an important topic in light of the on-going debate in the Directorate-General for Competition (DG COMP) about the evolution of Article 102 of the TFEU. The EC published draft guidelines on exclusionary conduct on August 2, 2024 however there is as yet no mention of disparagement. Equally, the Court of Justice of the European Union (CJEU) hasn’t yet ruled on disparagement as a unilateral conduct that violates Article 102 TFEU either.

    On June 20, 2022 after a complaint by Pharmacosmos, a Danish pharmaceutical company focused on the treatment of iron deficiency conditions, the EC opened a formal investigation into Vifor Pharma, a multinational pharmaceutical company based in Switzerland, for possible anticompetitive disparagement of iron medicine. Vifor allegedly disseminated misleading information regarding the safety of Pharmacosmos’ iron deficiency treatment, Monofer, with a view to boost its own intravenous iron medicine, Ferinject.

    The EC stated that Vifor embarked on a misleading communication campaign against Monofer that may have delayed its uptake. While the commitment decision is not public yet, the commitments provide a deductive insight into what the communication campaign may have entailed. For example, the proposed commitments of April 16, 2024 (see below) state that Vifor shall not imply or suggest that Monofer is dextran-based or dextran-derived which may result in an increased risk of hypersensitivity reactions (HSR) compared to Ferinject.

    In parallel with the EC, on January 31, 2024 the UK Competition and Markets Authority CMA also opened an investigation into Vifor in relation to the same concerns as in the EC’s case, namely whether Vifor’s claims regarding the safety and effectiveness of Monofer were misleading and hence amounted to an abuse of dominant position in the supply of iron deficiency treatments for patients of the National Health Service (NHS). The UK Prescription Medicines Code of Practice Authority (PMCPA) had already imposed sanctions on Vifor in 2016 for the breach of the Association of the British Pharmaceutical Industry Code (ABPI), for producing material which created doubt about the safety of Monofer, making misleading comparisons between Monofer and Ferinject, as well as sending an unsolicited promotional email from its medical information department that was allegedly not fair or balanced about adverse reactions.

    To address the EC’s concerns, on April 16, 2024, Vifor offered up a series of commitments. Firstly, Vifor committed to a clarifying communication campaign conveying that there is no evidence that calls Monofer’s safety into question with a view to undo the effects of the potentially misleading messages the company previously disseminated against Monofer. This includes the clarification that Monofer does not present an increased risk of any hypersensitivity reaction compared to Ferinject. These messages will be transmitted via mail, e-mail, medical journals and in-person meetings. They will also be made available on Vifor’s website; third parties, including Pharmacosmos, will also be allowed to use them.

    Secondly, Vifor committed not to engage in written or oral external promotional and medical communications within the EEA for the next ten years, that contain information that is not based on or included in Monofer’s Summary of Product Characteristics (SmPC, the officially approved conditions of the efficient and safe use of a medicinal product) nor which are not derived from a clinical head-to-head trial between Ferinject and Monofer.

    Lastly, Vifor Pharma committed to implement measures and safeguards to ensure compliance of promotional and medical communications and of internal training materials with the EC’s competition regime. This includes annual staff trainings and certification of compliance.

    On July 22, 2024, two years after the investigation was opened, the EC accepted Vifor’s commitments.

    Interestingly, the EC did not come to a definite conclusion on whether there was an infringement of Article 102 TFEU, but it found that there are no grounds for further action. In this context, it is also worth noting that Teva received a second Letter of Facts from the EC in May 2024, to which it responded in June 2024, though it may have concerned the patent limb of the EC’s investigation.

    Assessment of Disparagement by Regulatory Authorities So Far

    In the European Union, a series of investigations have been conducted, mainly at a national level, addressing the disparaging practices of incumbents to curb the uptake of generic products. Disparagement cases have been particularly prominent in France, where they have become a significant line of antitrust law with regard to the pharmaceutical sector. The French Competition Authority (FCA), followed by other National Competition Authorities (NCAs) – Italian, Belgian, Danish – has been a pioneer in relation to disparagement practices under both national and EU competition legal frameworks for over a decade. Four out of its ten disparagement cases address the pharmaceutical industry.

    As far as case law on an EU level goes, the Court of Justice of the European Union (CJEU) has held on a preliminary ruling that disparagement practices may constitute a “by object” infringement of EU competition law under the scope of Article 101 TFEU. In another case, the CJEU held that certain forms of comparative advertising are unlawful if they are misleading or discrediting.

    The FCA’s practice is a useful tool when it comes to the assessment of disparagement. According to the consistent practice of the FCA, disparagement differs from criticism in that it comes from an economic actor who seeks to gain a competitive advantage by penalizing his competitor. In each of its decisions relating to the pharmaceutical sector, the FCA imposed sanctions on the disparaging party under article 102 TFEU as well as the French commercial code (article L. 420-2) and followed an effects-based approach i.e. the conduct was found abusive based on the effects it had on the market/consumers. Typically, in such disparagement cases, the dominant company conducted a systematic, extensive misinformation campaign, targeting individuals who either make or influence purchasing decisions (e.g. healthcare professionals, such as pharmacists, doctors, etc.).

    Through its four cases that focus on the pharmaceutical industry, the FCA established four criteria in order to assess disparagement as an abusive conduct: (1) dominant position held by the disparaging company, (2) disparagement of a competitor’s product (through a commercial strategy aimed at gaining an advantage over a competitor’s product), (3) establishment of a link between the dominant position and the disparagement conduct, and (4) actual or potential effects on the market.

    It is worth noting that the Paris Court of Appeal (PCA) overturned one of the FCA’s decisions. This particular case concerned not an originator and a generic product, but a product that had received marketing authorization (MA) for the treatment of ophthalmological conditions and one that was prescribed “off label”. The PCA found that this raised the threshold for establishing disparagement. More specifically, it took into account the contribution of the communication campaign to a public interest debate, the neutral tone of the campaign and the factual accuracy of the disseminated information.

    Also notable is the Danish Competition Council’s (DCC) assessment of disparagement, which also deviated from the FCA’s practice. The DCC concluded that regardless of the accuracy and truthfulness of the dispersed information, the covert nature of the strategy could still limit competition and be deemed abusive.

    What’s Next? Future Assessment of Disparagement

    While the concept of disparagement as a potential abuse of dominant position is new at EU level, the EC has the NCA’s guidance to follow. The outcome of the Teva case will likely shed further light on the EC’s approach to disparagement.

    Despite the regulators’ recent attention to disparagement as a possible violation of competition law, as AG Rantos recalls in SEN, “…statements targeting or denigrating competitors are commonplace in an environment of competition on the merits, and should be considered relevant only when they are part of a foreclosure strategy”. Therefore, a balance has to be struck between the ability to highlight the differences between products, which is an essential part of competition, as companies strive to distinguish their products on quality and efficacy, on the one hand, and disparagement based on wrong or misleading facts on the other.

    *Trainee Maira Aivalioti also contributed to this article.

    Authors
    More insights

  • FTC’s Final Noncompete Rule Insights and Resources

    FTC’s Final Noncompete Rule Insights and Resources

    ARTICLE

    FTC’s Final Noncompete Rule Insights and Resources

    August 2024

    Read time: 4 min

    Key takeaways
    Overview

    On April 23, 2024, the Federal Trade Commission (FTC) voted to ban all employers from using noncompete clauses. Providing that employers’ use of noncompete agreements amounts to an “unfair method of competition” that runs afoul of Section 5 of the FTC Act, the Final Rule bans all new noncompete agreements nationwide and renders existing noncompete agreements binding most workers unenforceable.

    McDermott is closely tracking the Final Rule and related litigation as it proceeds. Explore our available insights and resources to stay up to date. For any questions, please contact your regular McDermott lawyer or one of the contacts in the resources below.

    INSIGHTS

    Texas Court Issues Nationwide Injunction Striking Down the FTC Noncompete Ban: On August 20, 2024, the US District Court for the Northern District of Texas issued a nationwide injunction barring the Federal Trade Commission’s (FTC) Final Rule that bans all noncompete agreements. The Final Rule will not take effect on September 4, 2024, as planned.

    Pennsylvania Court Rejects Attempt to Block FTC Noncompete Ban: On July 23, 2024, 20 days after the Texas ruling, the US District Court for the Eastern District of Pennsylvania declined to stay the September 4, 2024, effective date for ATS Tree Services LLC.

    Texas Court Postpones FTC Noncompete Ban for Ryan LLC Parties: On July 3, 2024, the US District Court for the Northern District of Texas stayed the September 4, 2024, effective date of the Final Rule, preliminarily enjoining the FTC from enforcing the Final Rule against the parties to a lawsuit filed by Ryan LLC, a private tax services firm.

    Revisiting Trade Secret Strategies Following the FTC’s Ban on Noncompete Agreements: The Final Rule marks a pivotal moment for trade secret protection and enforcement strategies as it promises to reshape the relationship between employers and employees and impact safeguards for proprietary information.

    FTC Issues Rule Banning Worker Noncompete Agreements: The FTC voted 3-2 along party lines to ban all new noncompete agreements and render existing noncompete agreements binding most workers unenforceable.

    FTC Proposes Rule Banning Noncompete Agreements: The FTC’s noncompete ban was first proposed on January 5, 2023, on the heels of the FTC’s policy statement in November 2022 asserting its intention to rigorously enforce and expand the scope of Section 5 of the FTC Act’s ban on unfair methods of competition.

    WEBINARS

    FTC’s Final Noncompete Rule: Developing Your Game Plan: Dive into the legal-, practical employment-, and executive compensation-related issues legal and human resources teams should consider if the Final Rule is upheld in full or in large part through this webinar’s key takeaways and recording.

    FTC’s Final Noncompete Rule: What It Means and Next Steps for Employers: View the key takeaways from and recording of a webinar that explains the impact of the Final Rule on current noncompete agreements, examines the legal issues around enforcing a noncompete ban and ensuing litigation, and outlines what employers should do next.

    What Employers Need to Know Now About the FTC’s Proposed Noncompete Ban: Hear insights from our multidisciplinary team of employment and antitrust lawyers regarding the impact of the rule and legal challenges when the rule was first proposed.

    IN THE NEWS

    FTC, State Scrutiny of Noncompetes Shift Labor Market, Modern Healthcare

    Private Equity Eyes Creative Solutions to FTC Non-compete Ban’s Impact, Mergermarket

    Noncompete Limits Pursued by States to Boost Health Workforce, Bloomberg Law

    Nonprofit Hospitals Aren’t Immune to FTC’s Noncompete Ban, Lawyers, Fitch Analysts Say, Fierce Healthcare

    In depth
    Authors
    More insights

  • Texas Court Strikes Down FTC Non-Compete Rule

    Texas Court Strikes Down FTC Non-Compete Rule

    ARTICLE / CLIENT ALERT

    Texas Court Strikes Down FTC Non-Compete Rule

    August 20, 2024

    Read time: 2 min

    Key takeaways
    Overview

    This afternoon, Judge Ada Brown of the US District Court for the Northern District of Texas issued a ruling that strikes down the Federal Trade Commission’s (“FTC”) final rule (the “FTC Rule”) prohibiting the use of noncompetition restrictions in the workplace. Judge Brown held that the FTC exceeded its authority in issuing a non-compete ban and that the FTC Rule was “arbitrary and capricious.” The Court held that the FTC Rule is “unlawful” and set the FTC Rule aside on a nationwide basis. Consequently, the FTC Rule will not take effect anywhere in the United States, and employers have no obligation to issue the notice to current and former employees regarding nonenforcement of noncompetes on or before Sept. 4, 2024 that would have been required had the FTC Rule taken effect.

    Please reach out to your Schulte contacts to discuss the decision and any related restrictive covenant issues.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2024 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights

  • FTC Announces Rule to Crack Down on Fake Reviews

    FTC Announces Rule to Crack Down on Fake Reviews

    ARTICLE / CLIENT ALERT

    FTC Announces Rule to Crack Down on Fake Reviews

    August 19, 2024

    Read time: 5 min

    Key takeaways
    Overview

    On August 14, 2024, the Federal Trade Commission (FTC) announced a final rule that identifies a variety of online review-related practices as unfair or deceptive trade practices. This includes (i) implying that reviews exist when they do not, (ii) posting fake reviews, (iii) paying for positive or negative reviews and (iv) having insiders post reviews without disclosing their relationship to the company. The final rule also makes it an unfair or deceptive practice for companies to suppress or take actions to suppress reviews. In short, the FTC’s new rule attempts to crack down on what it sees as a manipulation of online reviews by companies.

    If you are a company that solicits reviews or obtains reviews online, it is important to understand the contours of this new rule and ensure that your practices comply with it.

    In depth

    Who Does the Final Rule Apply To?

    The FTC’s rule applies broadly to any business (subject to FTC authority) that sells products or services. In short, most for-profit companies in the US are subject to this new rule.

    What Is a Consumer Review?

    A consumer review is a “consumer’s evaluation, or a purported consumer’s evaluation, of a product, service, or business that is submitted by the consumer or purported consumer and that is published to a website or platform dedicated in whole or in part to receiving and displaying such evaluations.”

    This broad definition captures not only narrative reviews but also star ratings or rankings (e.g., one star).

    What the Final Rule Does

    The rule has several distinct parts, each which seeks to limit what the FTC has now labeled as unfair or deceptive trade practices:

    1. Fake or False Consumer ReviewsThe rule declares it an unfair or deceptive trade practice for a company to buy, sell or host reviews that they know or should have known to be from someone who did not have experience with the product or service.
    2. Buying Positive or Negative Consumer Reviews

      Under the rule, it is an unfair and deceptive trade practice to pay for or condition services on submitting a positive or negative review.
    3. Threatening Consumers to Remove Negative Reviews

      The rule also deems it an unfair or deceptive trade practice for a business to threaten consumers to remove their negative reviews.
    4. Publishing Reviews From Company Insiders Without Disclosing the Relationship

      It is now an unfair or deceptive trade practice for officers or managers of a company to submit a review without disclosing their relationship to the company.
    5. Suppressing Reviews

      The rule makes clear that it is an unfair and deceptive trade practice to suppress reviews for reasons other than content moderation (e.g., foul language, violations of terms of service). Companies cannot pick and choose which reviews are represented as the newest or most helpful, for example.
    6. Buying or Selling Fake Social Media Likes, Followers, Etc.

      Finally, the rule declares it an unfair or deceptive trade practice for anyone to buy or sell fake indicators of social media influence (e.g., bots or fake accounts that increase likes, views, comments or other social media engagement).

    What Are the Penalties?

    As with any other FTC claim of an unfair or deceptive trade practice, the FTC can bring an enforcement action seeking in excess of $50,000 per alleged violation.

    When Does the Final Rule Take Effect?

    The new rule will go into effect on October 13, 2024, 60 days after it is published in the Federal Register.

    Preparing for the Final Rule

    Almost every company on the internet seeks out positive reviews. Indeed, there is an entire ecosystem of companies that assist companies in obtaining positive reviews and otherwise promoting products online. In light of this new rule, companies that offer consumer products in particular will want to examine their practices for soliciting reviews and posting (or suppressing reviews) to ensure compliance with this new rule.

    McDermott can help companies navigate this rule and ensure that consumer reviews and testimonial practices are consistent with it. If you have any questions or would like to analyze your review compliance practices, please reach out to your McDermott lawyer or the authors.

    Authors

    David P. Saunders

    Partner

    Chicago

    More insights

  • English High Court Enforces Asymmetric Jurisdiction Clause in a Syndicated Loan Facility Agreement

    English High Court Enforces Asymmetric Jurisdiction Clause in a Syndicated Loan Facility Agreement

    ARTICLE / CLIENT ALERT

    English High Court Enforces Asymmetric Jurisdiction Clause in a Syndicated Loan Facility Agreement

    August 17, 2024

    Read time: 6 min

    Key takeaways
    Overview

    On 24 May 2024, the English High Court granted final injunctive relief to Barclays Bank Plc (Barclays), both in the form of an anti-suit injunction and an anti-enforcement injunction, arising out of a syndicated loan agreement (the Facility) entered into between Barclays and PJSC Sovcombank (Sovcombank).1 In a judgment that will be of interest to financial institutions and investors involved in cross-border disputes and to the public loan market, the English Courts have demonstrated a willingness to enforce asymmetric jurisdiction clauses, which are commonly seen in the syndicated loans market.

    In depth

    Background

    The Facility is governed by English law, and includes a provision granting the English Courts exclusive jurisdiction in all relevant aspects so far as actions brought by Sovcombank are concerned (albeit, the Facility enables Barclays to commence proceedings elsewhere).

    Following the imposition of sanctions on Sovcombank, Barclays was prevented from making payments to Sovcombank under the Facility (in his Judgment, Mr Justice Foxton noted that he was “satisfied” that the sanctions “had the legal effect of preventing Barclays from making payments to Sovcombank under the Facility”2). Despite, however, the inclusion of the (asymmetric) jurisdiction clause in the Facility, Sovcombank commenced proceedings in Russia against Barclays, seeking damages for the non-payment of amounts that it claimed were due under the Facility, relying on various provisions of the Russian Civil Code (the Russian Proceedings).

    It was Barclays’ position that the Russian Proceedings were issued in breach of the exclusive jurisdiction clause in the Facility. As such, Barclays obtained an interim anti-suit injunction from the English Court against Sovcombank and its assignee, LLC Sodeistvie Mezhdunarodnym Raschetam (referred to as AIS in the Judgment), aimed at restraining the Russian Proceedings. Barclays then applied for final injunctive relief in the form of an anti-suit injunction and an anti-enforcement injunction, and for a declaration that Barclays was not liable on the claim advanced in the Russian Proceedings. Neither Sovcombank or AIS responded to, or participated in, the English proceedings.

    The High Court’s Decision

    Barclays was granted the relief sought in its application (save for one amendment to the wording of the declaratory relief sought).

    Anti-Suit Injunction

    The Court was satisfied that the claim brought in the Russian Proceedings “is one that falls full square within the exclusive jurisdiction clause [in the Facility]”3, and that the pursuit of the Russian Proceedings is a breach of the exclusive jurisdiction clause. The Court decided that it was just and equitable to grant the anti-suit injunction, and that there were no strong reasons not to grant the injunctive relief sought to enforce the parties’ contractual bargain (adopting the same reasons given by HHJ Pelling KC when the interim injunctive relief was granted).

    Anti-Enforcement Injunction

    As to the anti-enforcement injunction, the Court noted that, although there is no separate jurisdictional requirement of “exceptionality” for the granting of such relief (over and above the reasons for granting anti-suit injunctive relief)”4, in practice “it is likely to be a rare case in which it will be possible to persuade a court to grant such an injunction”5. Nevertheless, the Judge was satisfied that this was such a case.

    The Court was presented with expert evidence to the effect that, even if the respondent to the anti-suit injunction had sought to discontinue the Russian Proceedings, the approval of the Court would be required, that the approval may not be granted, and that judgment might be entered regardless”<6/sup>. The Court was satisfied that the anti-suit injunction may not be effective, either because it will not be complied with, or, even if it is complied with, a judgment may be entered in the Russian Proceedings in any event. As such, and noting that the anti-enforcement injunction was sought at an early stage of the Russian Proceedings, and before the Russian Court had issued any judgment, the Court found that it was appropriate to also grant the anti-enforcement injunction.

    Declaration

    The declaration sought by Barclays was that it “is not liable to [Sovcombank or AIS] on the claim advanced in the Russian proceedings…””7. The Court found that such a declaration would serve a useful purpose in these proceedings, particularly when made by the Court that the parties have agreed has exclusive jurisdiction, and which is the jurisdiction which is the source of the law which the parties have agreed should govern their contract, and where what is in issue is the effect of sanctions imposed in the English jurisdiction. The Court was persuaded that the sanctions extend to the payments Barclays would otherwise have been required to make under the Facility, and that there “was no breach by Barclays of the Facility in not making the payment which might otherwise have been due to Sovcombank””8. Consequently, the Court dismissed the basis of the claim in the Russian Proceedings that Barclays had committed a legal wrong by not paying Sovcombank under the Facility.

    As such, the Court granted Barclays the declaration sought, subject only that the words “for damages” should be inserted immediately after the word “claim” in the declaration.

    English Legal Representation

    Finally, the Court also dismissed AIS’ suggestion in correspondence that it may be in difficulty in obtaining English legal representation, noting that “there has been a significant period in which it has been able to invoke the licence provisions by which it is possible to instruct English lawyers, notwithstanding the effect of sanctions”. The Court surmised that the more likely reason for Sovcombank’s and AIS’ non-participation in the English proceedings is “a considered decision not to participate because it has taken the view that it will focus its attentions on the Russian proceedings””9.

    Effect of the Court’s Decision

    As noted above, this Judgment demonstrates the willingness of the English Courts to enforce asymmetric jurisdiction clauses, which are common in the syndicated loans market. The English Courts have consistently held that asymmetric jurisdiction clauses are valid, in contrast to the approach taken in other jurisdictions.

    This is a Judgment that is likely to be welcomed by underwriters and other financial institutions, and reaffirms the principle that, where foreign proceedings are issued in breach of an exclusive jurisdiction clause (including the exclusive element of an asymmetric jurisdiction clause), the English Court will typically grant injunctive relief to hold the parties to the bargain that they struck (unless there are good reasons not to do so).

    Authors

    Mark Fine

    Partner

    London – 22 Bishopsgate

    Harry Denlegh-Maxwell

    Senior Associate

    London – 22 Bishopsgate

    More insights

  • FinCEN Issues Proposed Rule to Strengthen and Modernize AML/CFT Programs for Financial Institutions

    FinCEN Issues Proposed Rule to Strengthen and Modernize AML/CFT Programs for Financial Institutions

    ARTICLE / CLIENT ALERT

    FinCEN Issues Proposed Rule to Strengthen and Modernize AML/CFT Programs for Financial Institutions

    August 16, 2024

    Read time: 25 min

    Key takeaways
    Overview

    On June 28, 2024, the US Department of the Treasury’s Financial Crimes Enforcement Network (“FinCEN”) issued a notice of proposed rulemaking that would amend existing anti-money laundering/countering the financing of terrorism (“AML/CFT”) program[1] regulations to require that financial institutions establish, implement and maintain effective, risk-based and reasonably designed AML/CFT programs with certain minimum components, including a mandatory risk assessment process (hereinafter, “Proposed Rule”).[2] For purposes of the Proposed Rule, “financial institutions” include: banks; broker dealers; mutual funds; futures commission merchants (“FCMs”) and introducing brokers in commodities (“IB-Cs”); insurance companies; money services businesses (“MSBs”); casinos and card clubs; dealers in precious metals, precious stones or jewels; operators of credit card systems; loan or finance companies; and housing government sponsored enterprises.[3] In addition to establishing minimum risk assessment requirements for these AML/CFT programs, the Proposed Rule would require that financial institutions document each component of their AML/CFT programs and make this documentation available to FinCEN or its designee, which can include the appropriate agency to which FinCEN has delegated examination authority,[4] or the appropriate SRO.[5] The Proposed Rule would also require that these AML/CFT programs be approved and overseen by the financial institution’s board of directors or, if the financial institution does not have a board of directors, an equivalent governing body.

    Additionally, on August 9, 2024, the Board of Governors of the Federal Reserve System, the Federal Deposit Insurance Corporation, the National Credit Union Administration and the Office of the Comptroller of the Currency (collectively, the “Agencies”) issued a joint notice of proposed rulemaking that proposes amendments to their respective AML/CFT program rules to align those rules with the Proposed Rule.[6] The intent of the Agencies is to have their AML/CFT program requirements for banks remain consistent with those imposed by FinCEN.[7]

    The public comment period for the Proposed Rule will remain open until Sept. 1, 2024. FinCEN proposed that the final rule be effective six months from the date of the issuance of the final rule. The public comment period for the Agencies’ Proposed Rule will remain open until Oct. 8, 2024.

    Background for Proposed AML/CFT Program Enhancements

    In order to more fully understand the purpose of the Proposed Rule, it must be read in the context of various other steps taken by FinCEN to enhance AML/CFT programs, including prior FinCEN rulemaking activity and passage of the Anti-Money Laundering Act of 2020 (“AML Act”). For example, prior to the enactment of the AML Act, FinCEN published an advanced notice of proposed rulemaking seeking public comment on potential regulatory amendments to increase the effectiveness of the existing AML program rules (“Effectiveness ANPRM”).[8] Specifically, the Effectiveness ANPRM proposed amending the Bank Secrecy Act (“BSA”) to explicitly define an “effective and reasonably designed” AML/CFT program as one that (i) identifies, assesses and reasonably mitigates the risks resulting from illicit activity consistent with the institution’s risk profile and the risks communicated by relevant government authorities as national AML/CFT priorities; (ii) assures and monitors compliance with the recordkeeping and reporting requirements of the BSA; and (iii) provides information with a high degree of usefulness to government authorities consistent with both the institution’s risk assessment and the risks communicated by relevant government authorities as national AML/CFT priorities.[9] The Effectiveness ANPRM signaled FinCEN’s intention for AML program rules to provide financial institutions with greater flexibility in the allocation of resources and better align AML priorities across industry and government. It also sought comment on whether FinCEN should amend its regulations to explicitly require financial institutions to implement risk assessment processes and whether FinCEN should publish AML priorities that financial institutions would incorporate into their risk assessments. There was broad agreement among commenters that the rulemaking was an important opportunity to modernize AML programs in order to manage money laundering/terrorist financing (“ML/TF”)[10] risks more effectively and efficiently.[11]  

    In the preamble to the Proposed Rule, FinCEN expressed its intent that the Proposed Rule work in concert with the AML Act to promote critical feedback loops among FinCEN, law enforcement, financial institutions and financial regulators.[12] Several provisions of the AML Act advance this goal of promoting feedback loops, including: (i) the establishment of a public-private information sharing partnership among law enforcement agencies, national security agencies, financial institutions and FinCEN;[13] (ii) the establishment of an Office of Domestic Liaison with liaisons located across the country to facilitate information sharing between financial institutions and FinCEN, as well as their federal functional regulators, state bank supervisors and state credit union supervisors;[14] (iii) the establishment of a supervisory team of relevant federal agencies, private sector experts and other stakeholders to examine strategies to increase cooperation between the public and private sectors;[15] (iv) the requirement that FinCEN periodically publish threat pattern and trend information regarding the preparation, use and value of Suspicious Activity Reports (“SARs”) filed by financial institutions;[16] (v) the requirement that the Attorney General provide an annual report on the use of BSA data derived from financial institutions’ BSA reporting;[17] and (vi) the requirement that FinCEN, to the extent practicable, provide particularized feedback to financial institutions on their SARs.[18]

    FinCEN also views the Proposed Rule as an important component in furtherance of the Department of the Treasury’s April 2023 De-Risking Strategy (“De-Risking Strategy”) issued pursuant to the AML Act.[19] De-risking refers to the phenomenon whereby financial institutions – rather than taking reasonable steps toward risk mitigation – opt to terminate or restrict business relationships with particular clients or categories of clients in an effort to avoid risk or liability associated with AML/CFT compliance obligations. The De-Risking Strategy identified the customer categories most impacted by de-risking as small- and medium-sized MSBs, non-profit organizations operating abroad in high-risk jurisdictions and foreign financial institutions with low correspondent banking transaction volumes, particularly where there are high ML/TF risks.[20]

    FinCEN notes that the effectiveness of implementation of the Proposed Rule by financial institutions would largely depend on the strength of their cultures of compliance.[21] As described in FinCEN’s 2014 culture of compliance advisory (“2014 Advisory”), a culture of compliance involves demonstrable support and visible commitment from leadership, the dedication of adequate resources to AML/CFT compliance, effective information sharing throughout the financial institution, qualified and independent testing, and an understanding across leadership and staff levels of the importance of BSA reports.[22] In a broader effort to modernize the AML/CFT regime, FinCEN is reviewing its 2014 Advisory and welcomes comment on whether additional guidance on promoting a culture of compliance within financial institutions is needed.

    Proposed Components of an Effective, Risk-Based and Reasonably Designed AML/CFT Program

    The AML Act notes that “effective” AML/CFT programs safeguard national security and generate significant public benefits by (i) preventing the flow of illicit funds into the US financial system and (ii) assisting law enforcement and national security agencies with the identification and prosecution of persons attempting to launder money and undertake other illicit finance activity through the US financial system.[23] The AML Act further provides that AML/CFT programs are to be risk-based and reasonably designed to assure and monitor compliance with the requirements of the BSA.[24] The Proposed Rule would implement these statutory provisions of the AML Act by explicitly requiring financial institutions to establish, implement and maintain effective, risk-based and reasonably designed AML/CFT programs. The current program rules use inconsistent terms across financial institutions to describe AML/CFT requirements.[25] To improve consistency, the Proposed Rule would apply the same set of terms to describe establishing, implementing and maintaining AML/CFT programs.[26] Importantly, FinCEN does not intend for these changes to substantively change current regulatory expectations.[27]  

    Under the Proposed Rule, an effective, risk-based and reasonably designed AML/CFT program would need to include, at a minimum:

    1. A risk assessment process that serves as the basis for the financial institution’s AML/CFT program;
    2. Internal policies, procedures and controls that are commensurate with the financial institutions’ ML/TF risks and ensure ongoing compliance with the BSA and its implementing regulations;
    3. A qualified AML/CFT officer who is accessible to, and subject to oversight and supervision by, FinCEN and the appropriate Federal functional regulator;
    4. An ongoing employee training program;
    5. Independent, periodic testing conducted by qualified personnel of the financial institution or by a qualified outside party; and
    6. Other requirements depending on the type of institution, such as customer due diligence (“CDD”).

    FinCEN expects that these components do not function in isolation, but rather complement each other. This holistic approach extends to the collection and use of information to identify and mitigate ML/TF risks, the consideration of resources, and the ongoing calibration of the AML/CFT program consistent with the financial institution’s risk assessment process.

    1. Risk Assessment Process

    The AML/CFT Program Proposed Rule would impose a new obligation on financial institutions to establish internal risk assessment processes that identify, evaluate and document the financial institution’s ML/TF risks, including consideration of: (i) the AML/CFT priorities issued by FinCEN, as appropriate; (ii) the ML/TF risks of the financial institution’s business activities, including products, services, distribution channels, customers, intermediaries, geographic locations and information obtained pursuant to section 314(b); and (iii) reports filed by the financial institution with FinCEN, such as SARs and Currency Transaction Reports (“CTRs”), Forms 8300, and other relevant BSA reports and advisories.[28]

    i. AML/CFT Priorities

    FinCEN proposes to add a new definition of “AML/CFT Priorities” that would refer to the most recent statement of AML/CFT Priorities FinCEN published on June 30, 2021.[29] Under the Proposed Rule, financial institutions would have to ensure that their risk assessment processes take into account changes to the AML/CFT Priorities as they become available.[30] FinCEN would be required to update these Priorities not less frequently than once every four years, and financial institutions would only be required to incorporate the most up-to-date set of AML Priorities into their risk-based AML/CFT programs.[31]

    ii. Identifying and Evaluating ML/TF and Other Illicit Finance Activity Risks

    In addition to the AML/CFT Priorities, the Proposed Rule would require a risk assessment process to incorporate other illicit finance activity risks based on the financial institution’s business activities, including products, services, distribution channels, customers, intermediaries and geographic locations.[32]

    “Distribution channels” refer to the methods and tools through which a financial institution opens accounts and provides products or services, including, for example, through the use of remote or other non-face-to-face means.[33]

    “Intermediaries” broadly include financial relationships other than customer relationships that allow financial activities by, at or through a financial institution.[34] An intermediary can include brokers, agents and suppliers that facilitate the introduction or processing of financial transactions, financial products and services, and customer-related financial activities.[35] One  example of an intermediary is where a broker-dealer establishes an omnibus account for a financial intermediary (such as an investment adviser) that, in turn, establishes a sub-account for the intermediary’s clients, whose information may or not be disclosed to the broker-dealer.[36] FinCEN notes that an intermediary may have its own independent obligations to comply with the BSA if it meets the definition of a financial institution subject to the BSA and FinCEN’s implementing obligations.[37]

    FinCEN encourages financial institutions to also consider information identified from responding to section 314(a) requests and information obtained from other financial institutions, such as emerging risks and typologies identified through section 314(b) information sharing.

    FinCEN requests comment as to whether: (a) additional explanation of “distribution channels” and “intermediaries” is required; (b) any other factors should be considered in determining the ML/TF risks of financial institutions’ business activities; and (c) further clarity is needed regarding the timeliness, completeness and accuracy of the information, analysis and documentation required as part of the risk assessment process.

    iii. Review of Reports, Including SARs, CTRs and Forms 8300

    The Proposed Rule would require financial institutions to review and evaluate reports filed by the financial institution with FinCEN pursuant to 31 C.F.R. chapter X, including SARs, CTRs and Forms 8300.[38] FinCEN notes that while many financial institutions already incorporate a review of SARs and CTRs into their AML/CFT programs, FinCEN included the review requirement in the Proposed Rule because such reports can provide financial institutions with a more complete understanding of their customers’ and their own ML/TF risk profiles, in addition to signaling areas of emerging risk as their products and services evolve and change.[39] FinCEN requests comment on the benefits and burdens that reviewing reports filed by the financial institution may present.

    iv. Frequency of Updates to Financial Institutions’ Risk Assessments

    Under the Proposed Rule, financial institutions would be required to update their risk assessments on a periodic basis, including, at a minimum, when there are material changes in their risk profile. For example, a financial institution would be required to update its risk assessment when new products, services and customer types are introduced, when existing products, services and customer types undergo material changes, or when the financial institution as a whole expands or contracts through mergers, acquisitions, sell-offs, dissolutions and liquidations.[40] FinCEN requests comment on whether additional clarity is needed with respect to the frequency financial institutions would be required to update their risk assessments and the material changes that would warrant such updates. FinCEN also requests comment on whether additional clarity is needed regarding the similarities and differences between a risk assessment process and a risk assessment, particularly with respect to the frequency and material changes requiring financial institutions to update their risk assessment using the process proposed in this rule.[41]

    2. Internal Policies, Procedures and Controls

    While the BSA already requires that financial institutions have internal controls as part of their AML/CFT programs, the Proposed Rule would impose a new obligation on financial institutions to take the steps necessary to ensure their internal policies, procedures and controls are commensurate with their specific ML/TF risks.[42] In particular, the Proposed Rule would require financial institutions to reasonably manage and mitigate risks using internal policies, procedures and controls that are adjusted to their institution-specific ML/TF risks using the required risk assessment process.[43] Importantly, the Proposed Rule would provide financial institutions with the regulatory flexibility to consider innovative approaches to complying with BSA, including determining not only the total amount of resources but also the nature of those resources in addressing the financial institution’s ML/TF risks.[44]

    FinCEN requests comment on several questions related to innovative approaches to BSA compliance, including whether there are aspects of the Proposed Rule that may be considered barriers to innovation and what, if any, innovative approaches and technology financial institutions currently use, or are considering using, such as artificial intelligence and machine learning.

    3. AML/CFT Officer

    The BSA already requires financial institutions that are obligated to have an AML/CFT program to have a designated AML/CFT officer, and there are slight variations in the existing AML/CFT officer requirements for different types of financial institutions.[45] The Proposed Rule would provide technical changes to this provision to promote clarity and consistency across all financial institutions. Specifically, the Proposed Rule would require AML/CFT programs to designate one or more qualified individuals to be responsible for coordinating and monitoring day-to-day compliance with the requirements and prohibitions of the BSA and FinCEN’s implementing regulations.[46]

    Under the Proposed Rule, whether an individual is sufficiently qualified as an AML/CFT officer will depend, in part, on the financial institution’s ML/TF risk profile, as informed by the results of the financial institution’s risk assessment process.[47] Among other criteria, a qualified AML/CFT officer would have the expertise and experience to adequately perform the duties of the position, including having sufficient knowledge and understanding of the financial institution as informed by the financial institution’s risk assessment process, US AML/CFT laws and regulations, and how those laws and regulations apply to the financial institution and its activities.[48] FinCEN notes that the actual title of the individual responsible for day-to-day AML/CFT compliance is not determinative and the person need not be an “officer” of the financial institution, but that the individual’s authority, independence and access to resources within the financial institution are critical. Relevant resources include: adequate compliance funds and staffing with the skills and expertise appropriate to the financial institution’s risk profile, size and complexity; an organizational structure that supports compliance and effectiveness; and sufficient technology and systems to support the timely identification, measurement, monitoring, reporting and management of the financial institution’s ML/TF and other illicit finance activity risks.[49] Importantly, FinCEN notes that an AML/CFT officer who has multiple additional job duties or conflicting responsibilities that adversely impact the officer’s ability to effectively coordinate and monitor day-to-day AML/CFT compliance would generally not fulfill the access-to-resources requirement.[50]

    While the AML/CFT officer provisions of the Proposed Rule would not impose new obligations on financial institutions, any changes in costs or burdens associated with these provisions would be based on how the financial institution’s risk assessment process impacts its specific ML/TF risk profile.

    4. Training

    The BSA already requires financial institutions to incorporate an ongoing employee training program into their AML/CFT program.[51] The Proposed Rule would amend these requirements to provide that, to be effective, risk-based and reasonably designed, an AML/CFT program must include an ongoing employee training program that is also risk-based. Specifically, the Proposed Rule would require financial institutions to focus their training programs on areas of risk as identified by the risk assessment process and base the periodic nature of their employee training programs on their specific ML/TF risk profile.[52] The Proposed Rule would also require financial institutions’ employee training programs to incorporate current developments and changes to AML/CFT regulatory requirements, in addition to other new information that is made available to them in connection with their AML/CFT program requirements.[53]

    5. Independent Testing

    The BSA already requires financial institutions to include independent testing in their AML/CFT programs.[54] The Proposed Rule would standardize the existing AML program rules to require that all financial institutions’ AML/CFT Programs include independent, periodic testing to be conducted by qualified personnel of the financial institution or by a qualified outside party.[55] While the independent testing component of the Proposed Rule does not add new obligations, any additional costs or burdens associated with this component would be based on how the financial institution’s risk assessment process impacts its specific ML/TF risk profile. Importantly, the Proposed Rule does not specify the frequency with which periodic independent testing is to be conducted. Rather, FinCEN expects the frequency of periodic independent testing to vary based on each financial institution’s risk profile and material changes to the financial institution’s risk profile and overall risk management strategy as informed by the financial institution’s risk assessment process.[56] FinCEN invites comment on whether and how the Proposed Rule’s addition of “periodic” to the independent testing component of the existing AML program rules will change this component of financial institutions’ AML/CFT programs. 

    6. Other Components of an Effective, Risk-based and Reasonably Designed AML/CFT Program

    The Proposed Rule would retain existing additional AML/CFT program rule requirements with minimal conforming changes. For example, the existing AML program CDD requirements, the use of automated systems, suspicious activity reporting, recordkeeping and the role of agents and brokers, would remain substantively unchanged.[57] However, the Proposed Rule would amend and add new obligations to the existing AML program rules to make these rules consistent across financial institutions. Such amended and revised requirements include the documentation of AML/CFT programs, AML/CFT program approval and oversight, and the AML/CFT program US person requirement.

    i. CDD Requirements

    The Proposed Rule would retain the existing CDD provisions for banks, broker-dealers, mutual funds, FCMs and IB-Cs.[58] However, the Corporate Transparency Act (“CTA”) requires FinCEN to revise the CDD Rule no later than one year after the effective date of the beneficial ownership information reporting regulations, which was Jan. 1, 2024.[59] FinCEN notes that the substance of the CDD Rule, and therefore the obligations of financial institutions, may change as a result of FinCEN’s revision to the CDD Rule.[60] FinCEN does not plan to propose changes to financial institutions’ CDD requirements until the revisions to the CDD Rule are completed.  

    ii. Availability Requirement

    While the AML Act already requires that financial institutions have written AML/CFT programs, there is some variation in the specific language used for different types of financial institutions. The Proposed Rule would provide a consistent standard by requiring that an AML/CFT program and each of its components be documented, and that such documentation be made available to FinCEN or its designee, which can include the appropriate agency to which FinCEN has delegated examination authority or the appropriate SRO.[61] While the Proposed Rule would not establish a new obligation with respect to AML/CFT program documentation, any additional compliance costs or burdens would be based on the financial institution’s risk assessment process and its impact on the financial institution’s AML/CFT program and underlying components.

    iii. Proposed AML/CFT Program Staff and Operations US Person Requirement

    The Proposed Rule would incorporate the existing AML Act requirement that the duty to establish, maintain and enforce the AML/CFT program must remain the responsibility of, and be performed by, persons in the US who are accessible to, and subject to oversight and supervision by, FinCEN and the financial institution’s federal functional regulator, if applicable.[62] FinCEN recognizes that many financial institutions have AML/CFT operations and staff outside of the US, or contract or delegate parts of their AML/CFT operations to third-party providers located outside of the US.[63] Accordingly, FinCEN requests comment on several questions related to this provision, including the scope of the US person requirement and the obligations of persons that are covered.

    iv. Proposed AML/CFT Board Approval and Oversight Requirements

    The Proposed Rule would modify the existing AML program rules to make the AML/CFT program approval and oversight requirements consistent across financial institution types.[64] Under the Proposed Rule, financial institutions must have their AML/CFT programs approved and overseen by their board of directors or, if the financial institution does not have a board of directors, an equivalent governing body.[65] For financial institutions without a board of directors, the equivalent governing body can take different forms. The equivalent governing body might be a sole proprietor, owner(s), general partner, trustee, senior officer(s), or other persons that have functions similar to a board of directors, including senior management.[66] For the US branch of a foreign bank, the equivalent governing body may be the foreign banking organization’s board of directors or delegates acting under the board’s express authority.[67] Although some financial institutions must already obtain board approval for their AML/CFT programs or be subject to oversight by a board of directors or equivalent governing body, the Proposed Rule’s approval and oversight requirement will represent a change in requirements for certain financial institutions.

    The Proposed Rule’s oversight requirement contemplates appropriate and effective oversight measures, such as governance mechanisms, escalation and reporting lines, to ensure that the financial institution’s board or equivalent governing body can properly oversee whether AML/CFT programs are operating in an effective, risk-based and reasonably designed manner.[68] FinCEN notes that, in some instances, the Proposed Rule’s focus on oversight may require changes to the frequency and manner of reporting to the board, which may in turn result in additional costs and burdens for affected entities.[69]

    FinCEN requests comment on several questions related to the board approval and oversight component of the Proposed Rule, including whether its requirement for board or equivalent governing body approval and oversight of AML/CFT programs is consistent with industry practice and whether the Proposed Rule should specify the frequency with which a board of directors or equivalent governing body must review, approve and oversee the financial institution’s AML/CFT program.

    v. Proposed Changes to Promote Modernization, Clarification and Consistency

    The Proposed Rule would make other revisions to modernize the AML/CFT program rules and promote consistency across the AML/CFT program rules applicable to all financial institutions. The majority of these changes are technical, such as renumbering provisions, amending cross-references and updating statutory references based on changes to the BSA from the AML Act.

    For example, the Proposed Rule would apply the existing AML program rules for banks lacking a federal regulator to the AML program rules for banks that do have a federal regulator, so it would no longer be necessary to have two sets of AML program rules for banks.[70] The existing AML program rule for banks lacking a federal regulator requires them to: (i) have their AML programs approved by the board of directors or, if the bank does not have a board of directors, an equivalent governing body within the bank; and (ii) make a copy of their AML programs available to FinCEN or its designee upon request.[71] In effect, the Proposed Rule would explicitly consolidate the approval, oversight and availability requirements discussed earlier in this Alert into a single set of rules applicable to all banks.

    Importantly, the Proposed Rule as it applies to broker-dealers, FCMs and IB-Cs would retain the existing requirement that their AML/CFT programs comply with the rules, regulations or requirements of their governing SROs, provided the rules, regulations or requirements of their governing SROs have been made effective by the appropriate Federal functional regulator in consultation with FinCEN.[72]

    Takeaways

    The Proposed Rule is designed to promote consistency across FinCEN’s AML/CFT program rules for all financial institutions. If finalized as proposed, the Proposed Rule will require all financial institutions to engage in a risk assessment process. The Proposed Rule will also add new, more nuanced compliance obligations for financial institutions. Financial institutions should review their existing internal policies, procedures and controls to understand how the Proposed Rule may require changes. Financial institutions should also consider providing comments to FinCEN, including on the definitions of “distribution channels” and “intermediaries”; the frequency financial institutions would be required to update their risk assessments and the material changes warranting such updates; and the frequency of audits and reports to a board of directors or equivalent governing body, including the manner of reporting that would be required.

    Authored by Betty Santangelo, Melissa G.R. Goldstein, Kyle B. Hendrix and Noah A. Wright.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] Among other things, the Anti-Money Laundering Act of 2020 (“AML Act”) amended the Bank Secrecy Act to add a reference to “countering the financing of terrorism” as part of the requirement that financial institutions establish an AML program. AML Act, § 6101(a). According to FinCEN, the inclusion of “CFT” in the program rules is not anticipated to establish new obligations. FinCEN, Notice of Proposed Rulemaking, Anti-Money Laundering and Countering the Financing of Terrorism Programs, 89 Fed. Reg. 55428, 55435 (July 3, 2024), (hereinafter, “Proposed Rule”).

    [2] For more information regarding the AML Act generally, please see our prior Alert, “Passage of Anti-Money Laundering Act of 2020 Includes Comprehensive BSA/AML Reform Measures.”

    [3] Proposed Rule, 89 Fed. Reg. at 55428 (citing 31 C.F.R. § 1010.100(t) to (ff)). On Feb. 15, 2024, FinCEN proposed applying certain BSA requirements to certain investment advisers, including adding “investment adviser” to the definition of “financial institution” under the BSA. The proposed rule for certain investment advisers does not generally reflect the proposals in this Proposed Rule, but we assume that if the proposed rule for certain investment advisers is finalized as proposed, the Proposed Rule will ultimately incorporate those changes. For more information regarding FinCEN’s proposed AML/CFT program requirements for investment advisers, please see our prior Alert, “FinCEN Once Again Proposes Anti-Money Laundering Program Requirements for Investment Advisers.”

    [4] Proposed Rule, 89 Fed. Reg. at 55444 (citing 31 C.F.R. § 1010.810(b)).

    [5] Id. at 55444. For broker-dealers, FinCEN recognizes the SEC as the federal functional regulator, and registered national securities exchanges or national securities associations such as the Financial Industry Regulatory Authority, as the governing SROs. Id. at n.125. For FCMs and IB-Cs, FinCEN recognizes the Commodities and Futures Trading Commission as the federal functional regulator, and the National Futures Association as the governing SRO. Id.

    [6] Office of the Comptroller of the Currency, Federal Reserve, Federal Deposit Insurance Corporation and National Credit Union Association, Notice of Proposed Rulemaking, Anti-Money Laundering and Countering the Financing of Terrorism Program Requirements, 89 Fed. Reg. 65242 (Aug. 9, 2024).  

    [7] FinCEN, Office of the Comptroller of the Currency, Federal Reserve, Federal Deposit Insurance Corporation and National Credit Union Association, Interagency Statement on the Issuance of the AML/CFT Program Notices of Proposed Rulemaking (July 19, 2024).

    [8] FinCEN, Advanced Notice of Proposed Rulemaking, Anti-Money Laundering Program Effectiveness, 85 Fed. Reg. 58023 (Sept. 17, 2020).

    [9] Id. at 58026.

    [10] Proposed Rule, 89 Fed. Reg. at 55430. The Proposed Rule uses “ML/TF” to refer to risks and “AML/CFT” to refer to programs and priorities.

    [11] Congress enacted the AML Act shortly after FinCEN received comments on the Effectiveness ANPRM, and as a result, there was no further action on the Effectiveness ANPRM. Notably, many of the Effectiveness ANPRM’s proposals were superseded by the AML Act’s statutory amendments to the BSA.

    [12] Proposed Rule, 89 Fed. Reg. at 55432.

    [13] AML Act, § 6103.

    [14] AML Act, § 6107.

    [15] AML Act, § 6214.

    [16] AML Act, § 6206.

    [17] AML Act, § 6201.

    [18] AML Act, § 6203(a). See Proposed Rule, 89 Fed. Reg. at 55433 n.51.

    [19] Treasury, The Department of the Treasury’s De-Risking Strategy (April 2023).

    [20] De-Risking Strategy at 2.

    [21] Proposed Rule, 89 Fed. Reg. at 55434.

    [22] Id. (citing FIN-2014-A007, Advisory to U.S. Financial Institutions on Promoting a Culture of Compliance (Aug. 11, 2014)).

    [23] AML Act, § 6101(a).

    [24] Id.

    [25] Proposed Rule, 89 Fed. Reg. at 55436.

    [26] Id.

    [27] Id.

    [28] Proposed Rule, 89 Fed. Reg. at 55437.

    [29] FinCEN, Anti-Money Laundering and Countering the Financing of Terrorism Priorities (June 30, 2021).

    [30] Proposed Rule, 89 Fed. Reg. at 55440 n.95.

    [31] Id. at 55438.

    [32] Id.

    [33] Id.

    [34] Id. at 55439.

    [35] Id.

    [36] Id. at 55439 n.90.

    [37] Id. at 55439.

    [38] Proposed Rule, 89 Fed. Reg. at 55439.

    [39] Id.

    [40] Id. at 55440.

    [41] Id.

    [42] Proposed Rule, 89 Fed. Reg. at 55439.

    [43] Id. at 55440.

    [44] Id. (“For example, if the financial institution’s marketing or relationship management teams use internet or app-based data for commercial purposes, it would be reasonable for that financial institution’s AML/CFT program to consider using similar technology or approaches in managing and mitigating the financial institution’s ML/TF risks”).

    [45] Id. at 55441 (citing BSA, 31 U.S.C. § 5318(h)(1)(B)).

    [46] Id. at 55441.

    [47] Id.

    [48] Id.

    [49] Id.

    [50] Proposed Rule, 89 Fed. Reg. at 55441.

    [51] Id. at 55442 (citing BSA, 31 U.S.C. § 5318(h)(1)(C)).

    [52] Id. at 55442.

    [53] Id.

    [54] Id. at 55443 (citing BSA, 31 U.S.C. § 5318(h)(1)(D)).

    [55] Id. at 55443.

    [56] Id.

    [57] Proposed Rule, 89 Fed. Reg. at 55444.

    [58] Id.

    [59] AML Act, § 6403.

    [60] Proposed Rule, 89 Fed. Reg. at 55444 (citing FinCEN, Final Rule, Beneficial Ownership Information Access and Safeguards, 88 Fed. Reg. 88732 (Dec. 22, 2023), and codified at 31 C.F.R. §§ 1010.950 and 1010.955 (“BOI Access Rule”). The BOI Access Rule is the second of three rulemakings that will implement the CTA. The third rulemaking, which is still being drafted, will revise FinCEN’s customer due diligence rule to align it with the CTA. For more information regarding FinCEN’s BOI Access Rule, please see our prior Alert, “The Corporate Transparency Act: Final Rule on Access to Beneficial Ownership Information.”

    [61] Proposed Rule, 89 Fed. Reg. at 55444.

    [62] Id. at 55445 (citing AML Act, § 6101(a)).

    [63] Proposed Rule, 89 Fed. Reg. at 55445.

    [64] Id at 55444.

    [65] Id.

    [66] Id.

    [67] Id.

    [68] Id. at 55445.

    [69] Id.

    [70] Proposed Rule, 89 Fed. Reg. at 55446.

    [71] Id.

    [72] Id.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2024 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Betty Santangelo

    Counsel

    New York – 919 Third Avenue

    Melissa G.R. Goldstein

    Partner

    New York – 919 Third Avenue

    Kyle B. Hendrix

    Associate

    Washington, DC

    More insights

  • One Bite at the Apple Where State and Federal Jurisdiction Is Concurrent

    One Bite at the Apple Where State and Federal Jurisdiction Is Concurrent

    ARTICLE

    One Bite at the Apple Where State and Federal Jurisdiction Is Concurrent

    Aug 15, 2024

    Read time: 4 min

    Key takeaways
    Overview

    The US Court of Appeals for the Second Circuit upheld a federal district court’s dismissal of a case on res judicata grounds after a state court issued a decision on different claims but had concurrent jurisdiction over the claims alleged in the federal case. Beijing Neu Cloud Oriental Sys. Tech. Co. v. Int’l Bus. Machs. Corp., Case No. 22-3132 (2d Cir. July 25, 2024) (Livingston, Menashi, Kahn, JJ.)

    Beijing Neu Cloud Oriental System Technology filed suit in federal district court against several International Business Machines companies (collectively, IBM defendants) asserting a single claim for trade secret misappropriation under the Defend Trade Secrets Act (DTSA). Shortly thereafter, Neu Cloud also sued the IBM defendants in New York state court, alleging state law causes of action for unfair competition, unjust enrichment, breach of fiduciary duty, breach of contract and tortious interference.

    The state court dismissed the claims. After the state court issued its decision, the IBM defendants moved to dismiss the federal action, arguing that:

    • Neu Cloud’s claim was time-barred.
    • Neu Cloud failed to state a plausible DTSA claim.
    • The judgment of the New York Supreme Court precluded the instant DTSA claim under res judicata.

    The district court granted the motion to dismiss, agreeing with the IBM defendants on the DTSA claims but not on the effect of res judicata. Neu Cloud appealed the dismissal of its complaint. The Second Circuit only considered the arguments related to the IBM defendants’ res judicata defense.

    Applying New York law to determine the preclusive effect of the state court’s judgment, the Second Circuit explained that under New York preclusion law “a party may not litigate a claim where a judgment on the merits exists from a prior action between the same parties involving the same subject matter.” This rule applies if the subsequent claim was “actually litigated” in the prior action or if it merely “could have been raised in the prior litigation.”

    The Second Circuit found that the district court’s decision was on the merits and the trade secret claims could have been raised in the state court action. The Court held that the New York state court would have been competent to adjudicate the DTSA claim since jurisdiction for DTSA actions is not exclusive to federal courts. The Court noted that the plain text of the DTSA is strong evidence that Congress intended for jurisdiction over DTSA claims to be federal and state concurrent. Moreover, the Second Circuit found that the legislative history revealed no evidence that Congress affirmatively intended to confer exclusive jurisdiction over DTSA claims on the federal courts. The Court noted that many other circuit courts had come to the same conclusion.

    Since the parties were clearly the same, the state court case involved the same subject matter, and the claims alleged the same injury and arose out of the same or related facts, the Second Circuit stated that the relevant question was whether Neu Cloud should have sought recovery in state court for its claim of trade secret misappropriation under the DTSA. Resolving that issue, the Court found that both the federal and state complaints alleged the same facts and Neu Cloud’s state- aw and DTSA claims should have been brought in a single proceeding.

    The Second Circuit therefore affirmed the district court’s dismissal of the case.

    Authors
    More insights
    Endnotes

  • Don’t Share Trade Secrets With Your Fiancé: A Cautionary Tale

    Don’t Share Trade Secrets With Your Fiancé: A Cautionary Tale

    ARTICLE

    Don’t Share Trade Secrets With Your Fiancé: A Cautionary Tale

    Aug 15, 2024

    Read time: 4 min

    Key takeaways
    Overview

    The US Court of Appeals for the First Circuit largely affirmed a multimillion-dollar award against a temp agency for misappropriation of trade secrets and unjust enrichment due to its employee’s act of obtaining proprietary information from his fiancée, who worked at a competitor placement firm. BioPoint, Inc. v. Dickhaut, et al., Case No. 23-1575 (1st Cir. July 30, 2024) (Rikelman, Lynch, Howard, JJ.) (Rikelman, dissenting in part).

    BioPoint is a Massachusetts-based life sciences consulting firm that places highly skilled candidates in temporary positions at pharmaceutical, biopharmaceutical and medical device companies. Leah Attis was one of the company’s top salespeople. Catapult is a Texas-based placement company. It opened a Boston office in 2017 and hired Attis’s fiancé, Andrew Dickhaut, as managing director. When business did not go well at Catapult’s Boston office, Attis began to help Dickhaut place candidates by giving him proprietary information about candidates and rates from BioPoint’s database, even though Catapult did not initially operate in the life sciences sector. As a result, Catapult eventually entered into a managed services provider agreement with biotechnology company Vedanta, whereby Catapult would manage all of Vedanta’s labor contracts and would have the first opportunity to fill openings there. Attis continued to give Dickhaut information on candidates from BioPoint’s system to help with Vedanta openings.

    Upon discovering that it lost a candidate placement to Catapult because of Attis’s interventions, BioPoint fired her in December 2019. BioPoint then sued Catapult and Dickhaut for federal and state law claims, alleging misappropriation of trade secrets, tortious interference, and unfair and deceptive trade practices. The case proceeded to trial, and the district court divided the claims between a jury trial for the legal claims and a bench trial for equitable relief. The jury found that Catapult had misappropriated trade secrets and tortiously interfered with BioPoint’s relationship with the candidate that Attis helped Dickhaut place. The jury awarded BioPoint more than $300,000 in damages. At the bench trial on the equitable claims, the district court found that all profits that Catapult derived from its relationship with Vedanta arose on account of misappropriation of trade secrets and were recoverable as unjust enrichment. The district court awarded treble damages jointly against Dickhaut and Catapult, totaling more than $5 million. Catapult appealed.

    While the First Circuit largely affirmed the district court and the jury’s findings, the First Circuit found two errors. First, the Court found that the district court erred in awarding BioPoint both the lost profits from the placement of the candidate and the unjust enrichment that accrued to Catapult as the result of the placement. The Court explained that the law does not permit the lost profits to be counted twice and reduced the award by more than $150,000, which was the amount that the district court had awarded for the loss of the candidate.

    Second, the First Circuit found that the district court erred in finding Dickhaut jointly and severally liable for the entirety of his employer’s unjust enrichment, calling it “a bridge too far.” Since the profits accrued to Catapult, not Dickhaut, the Court found that it would be inconsistent with traditional equitable principles to impose joint-and-several liability on Dickhaut as an individual non-owner, non-director employee without analyzing whether or by how much he benefited from the scheme. The First Circuit remanded the separate calculation of Dickhaut’s unjust enrichment to the district court.

    Writing in partial dissent, Judge Rikelman took issue with the district court’s unjust enrichment award because it went “far beyond” the jury’s verdict regarding the extent of Catapult’s liability for using BioPoint’s trade secrets. Judge Rikelman argued that the district court erred as a matter of law in awarding the entirety of Catapult’s Vedanta profits to BioPoint because the jury found that only a fraction of Catapult’s life sciences consultant placements at Vedanta were due to trade secret misappropriation.

    Practice Note: As the dissent noted, the calculation of unjust enrichment damages in a trade secret misappropriation case “is not a precise science.” A causal nexus must be established between the misappropriation and the enrichment, and the enrichment itself can take several forms and cover a broad array of activity. There are differing legal theories available to assert and calculate unjust enrichment damages.

    Authors
    More insights
    Endnotes